Nanomedicine: The Minuten...
Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Safe-by-design and EU fun...
Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Swiss NanoConvention
Dr. Peter Wick represented contactpointnano and Empa at the Swiss NanoConvention in Neuchâtel (June 15-16, 2023). This year, the topics included nanoimaging, advanced manufacturing at nanoscale, smart
Pigments are Nano
A webinar by contactpointnano.ch Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented
Microplastics and Nanopla...
Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Clinam Summit in Basel
This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Developing trends in nano...
Waste containing nanomaterials — or nanowaste — is an emerging safety concern worldwide, warranting specific environmentally sound waste management and regulation. Authors: Arturo A. Keller, Alex Ehrens, Yuanfang Zheng & Bernd
Webinar: Open questions a...
Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Subscribe to our newslett...
Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Crucial results for coron...
Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
